BiotechTubeBiotechTube
Home/Pipeline/Metformin & Combinations

Metformin & Combinations

Type 2 Diabetes

CommercialActive

Key Facts

Indication
Type 2 Diabetes
Phase
Commercial
Status
Active
Company
Ipca Laboratories

About Ipca Laboratories

Ipca Laboratories Ltd. is a prominent, fully integrated Indian pharmaceutical company with a significant global footprint in over 120 countries. Its core strengths lie in its vertical integration, from API manufacturing to finished formulations, particularly in therapeutic segments like anti-malarials, NSAIDs, and anti-diabetics. The company has a diversified business model spanning domestic formulations, international branded generics, and API exports, and is strategically focused on expanding its presence in regulated markets like the US while navigating complex regulatory landscapes.

View full company profile

Therapeutic Areas

Anti-malarialsPain Management (NSAIDs)CardiovascularAnti-diabeticsAnti-infectivesGastrointestinalCNSDermatology

Other Type 2 Diabetes Drugs

DrugCompanyPhase
Tirzepatide (Mounjaro)Eli LillyApproved
OrforglipronEli LillyPhase 3
Trulicity (dulaglutide)Eli LillyApproved
ForxigaAstraZenecaApproved
siRNA GalXC-GYS2Novo NordiskPhase 1
Amylin/semaglutide combinationNovo NordiskPhase 3
LipaglynZydus LifesciencesApproved
LBS-009Belite BioPreclinical
Jentadueto (Linagliptin/Metformin)YuhanApproved
Nesina (Alogliptin)YuhanApproved
GSBR-1290Structure TherapeuticsPhase 2
MetforminGranules IndiaApproved/Commercial